Ms. Deborah Andrews's most recent trade in Staar Surgical Co. was a trade of 29,159 Performance Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 14 Aug 2026 | 29,159 | 29,159 | - | - | Performance Stock Option (right to buy) | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 14 Aug 2026 | 8,952 | 8,952 | - | - | Stock Option (right to buy) | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2026 | 5,233 | 41,452 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 14 Aug 2026 | 5,233 | 41,452 | - | - | Performance Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 14 Aug 2026 | 4,975 | 4,975 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.18 per share. | 14 Aug 2026 | 2,662 | 38,910 (0%) | 0% | 26.2 | 69,691 | Common Stock |
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 20,787 | 46,915 (0%) | 0% | - | Common Stock | |
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 25 Jun 2026 | 20,787 | 0 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | 25 Jun 2026 | 13,955 | 27,912 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 13,955 | 32,608 (0%) | 0% | - | Common Stock | |
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.36 per share. | 25 Jun 2026 | 10,576 | 36,339 (0%) | 0% | 24.4 | 257,631 | Common Stock |
| Staar Surgical Co. | Ms. Deborah Andrews | Chief Financial Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 25 Jun 2026 | 6,480 | 26,128 (0%) | 0% | 31.2 | 202,241 | Common Stock |
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 10,466 | 10,466 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | 15 May 2026 | 10,466 | 10,466 | - | - | Performance Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | 15 May 2026 | 5,233 | 15,699 | - | - | Performance Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 5,233 | 20,530 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 3,755 | 15,297 (0%) | 0% | 32.1 | 120,423 | Common Stock |
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 1,877 | 18,653 (0%) | 0% | 32.1 | 60,195 | Common Stock |
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | 13 Mar 2026 | 39,809 | 39,809 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | Interim Co-CEO and CFO | 02 Feb 2026 | 20,787 | 20,787 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Ms. Deborah Andrews | CFO | 25 Jun 2025 | 41,867 | 41,867 | - | - | Restricted Stock Units |